Skip to main content

Advertisement

Log in

Is drug consumption correlated with benign paroxysmal positional vertigo (BPPV) recurrence?

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Background

Benign paroxysmal positional vertigo (BPPV) is the most common cause of peripheral vertigo and its recurrence is fairly common. Several studies correlated the pathophysiological role of different comorbidities—such as diabetes, osteoporosis, vascular, psychiatric and autoimmune diseases—in the development and recurrence of BPPV. The aim of this study is to analyse the pharmacological history of patients with idiopathic BPPV in relation to the risk of developing recurrence.

Methods

Data regarding 715 patients aged 12 to 87 years (62.7 ± 14) with non-traumatic BPPV were retrospectively evaluated. These refer to the Vestibular Service, day clinic, and were collected over a 4-year period, between 2014 and 2018.

Results

Recurrence of BPPV was observed in 220/715 patients (30.76%). A statistically significant correlation (p < 0.006) between recurrence and drug consumption was observed for SNC agents (p = 0.0001), vitamin D (p = 0.0005), PPI (p = 0.0007), thyroid hormones (p = 0.0011), and antihypertensives in single use (p = 0.0031). On the contrary, cholesterol-lowering statin drugs, hypoglycaemic agents, antiplatelet medication, estroprogestins and combination of two or more antihypertensives did not show significant correlation.

Conclusion

Specific classes of drugs are significantly associated with recurrence: antihypertensive therapy with a singular agent, central nervous system agents, PPIs, vitamin D and thyroid hormones. On the other hand, the lack of correlation between some drugs and recurrence could be linked to the effectiveness of therapy in controlling hypertension, dyslipidaemia and diabetes. Pharmacological history is an essential tool to identify patients at risk of BPPV recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kim JS, Zee D (2014) Clinical practice benign paroxysmal positional vertigo. New Engl J Med 370(12):1138–1147

    Article  CAS  PubMed  Google Scholar 

  2. Palmeri R, Kumar A (2019) Benign paroxysmal positional vertigo (BPPV). Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470308. Accessed Jan 2019

  3. Faralli M, Ricci G, Molini E et al (2006) Paroxysmal positional vertigo: the role of age as a prognostic factor. Acta Otorhinolaryngol Ital 26(1):25–31

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Von Brevern M, Seelig T, Neuhauser H et al (2004) Benign paroxysmal positional vertigo predominantly affects the right labyrinth. J Neurol Neurosurg Psychiatry 75(10):1487–1488

    Article  Google Scholar 

  5. Bertholon P, Tringali S, Faye MB et al (2006) Prospective study of positional nystagmus in 100 consecutive patients. Ann Otol Rhinol Laryngol 115:587–594

    Article  PubMed  Google Scholar 

  6. Steenerson RL, Cronin GW, Marbach PM (2005) Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo. Laryngoscope 115:226–231

    Article  PubMed  Google Scholar 

  7. Barany R (1921) Diagnose von krankheitserscheinungen im. Bereiche des otolithenapparates [in German]. Acta Otolaryngol 2:434–437

    Article  Google Scholar 

  8. Schuknecht HF (1969) Cupulolithiasis. Arch Otolaryngol 90:765–778

    Article  CAS  PubMed  Google Scholar 

  9. Parnes LS, McClure JA (1992) Free-floating endolymph particles: a new operative finding during posterior semicircular canal occlusion. Laryngoscope 102:988–992

    Article  CAS  PubMed  Google Scholar 

  10. Talaat HS, Abuhadied G, Talaat AS et al (2015) Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol 272:2249

    Article  PubMed  Google Scholar 

  11. Moon SY, Kim JS, Kim BK et al (2006) Clinical characteristics of benign paroxysmal positional vertigo in Korea: a multicenter study. J Korean Med Sci 21:539–543

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hughes CA, Proctor L (1997) Benign paroxysmal positional vertigo. Laryngoscope 107(5):607

    Article  CAS  PubMed  Google Scholar 

  13. Dispenza F, De Stefano A, Mathur N et al (2011) Benign paroxysmal positional vertigo following whiplash injury: a myth or a reality? Am J Otolaryngol 32(5):376

    Article  PubMed  Google Scholar 

  14. Lee NH, Ban JH, Lee KC et al (2010) Benign paroxysmal positional vertigo secondary to inner ear disease. Otolaryngol Head Neck Surg 143(3):413

    Article  PubMed  Google Scholar 

  15. De la Meilleure G, Dehaene I, Depondt M et al (1996) Benign paroxysmal positional vertigo of the horizontal canal. J Neurol Neurosurg Psychiatry 60(1):68–71

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zucca G, Valli S, Valli P et al (1998) Why do benign paroxysmal positional vertigo episodes recover spontaneously? J Vestib Res 8(4):325–329

    Article  CAS  PubMed  Google Scholar 

  17. Brandt T, Huppert D, Hecht J et al (2006) Benign paroxysmal positioning vertigo: a long-term follow-up (6–17 years) of 125 patients. Acta Otolaryngol 126(2):160–163

    Article  PubMed  Google Scholar 

  18. Ahn SK, Jeon SY, Kim JP et al (2011) Clinical characteristics and treatment of benign paroxysmal positional vertigo after traumatic brain injury. J Trauma 70(2):442–446

    Article  PubMed  Google Scholar 

  19. Choi SJ, Lee JB, Lim HJ et al (2012) Clinical features of recurrent or persistent benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 147(5):919–924

    Article  PubMed  Google Scholar 

  20. Yoda S, Cureoglu S, Yildirim-Baylan M et al (2011) Association between type 1 diabetes mellitus and deposits in the semicircular canals. Otolaryngol Head Neck Surg 145:458–462

    Article  PubMed  Google Scholar 

  21. Jang YS, Kang MK (2009) Relationship between bone mineral density and clinical features in women with idiopathic benign paroxysmal positional vertigo. Otol Neurotol 30:95–100

    Article  PubMed  Google Scholar 

  22. Jeong SH, Choi SH, Kim JY et al (2009) Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology 72(12):1069–1076

    Article  PubMed  Google Scholar 

  23. Faralli M, Ricci G, Molini E et al (2006) Paroxysmal positional vertigo: the role of age as a prognostic factor. Acta Otorhinolaryngol Ital 26:25–31

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Eckhardt-Henn A, Best C, Bense S et al (2006) Psychiatric comorbidity in different organic vertigo syndromes. J Neurol 255:420–428

    Article  Google Scholar 

  25. Modugno GC, Pirodda A, Ferri GG et al (2006) A relationship between autoimmune thyroiditis and benign paroxysmal positional vertigo? Med Hypotheses 54:614–615

    Article  Google Scholar 

  26. Picciotti PM, Lucidi D, De Corso E et al (2006) Comorbidities and recurrence of benign paroxysmal positional vertigo: personal experience. Int J Audiol 55(5):279–284

    Article  Google Scholar 

  27. De Stefano A, Dispenza F, Suarez H et al (2014) A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx 41:31–36

    Article  PubMed  Google Scholar 

  28. Messina A, Casani AP, Manfrini M et al (2017) Italian survey on benign paroxysmal positional vertigo. Acta Otorhinolaryngol Ital 37:328–335

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Pellacani A, Brunner HR, Nussberger J (1994) Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci 87:567–574

    Article  CAS  PubMed  Google Scholar 

  30. Marceau F, Hess JF, Bachvarov DR (1998) The B1 receptors for kinins. Pharmacol Rev 50:357–386

    CAS  PubMed  Google Scholar 

  31. Shi X (2011) Physiopathology of the cochlear microcirculation. Hear Res 282(1–2):10–24

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ferrari S, Monzani D, Baraldi S et al (2014) Vertigo ‘‘in the pink:’’ the impact of female gender on psychiatric–psychosomatic comorbidity in benign paroxysmal positional vertigo patients. Psychosomatics 55:280–288

    Article  PubMed  Google Scholar 

  33. Warninghoff JC, Bayer O, Ferrari U et al (2009) Co-morbidities of vertiginous diseases. BMC Neurol 7(9):29

    Article  Google Scholar 

  34. Serif SK, Cengiz A, Umit SC et al (2017) The evaluation of anxiety and panic agarophobia scores in patients with benign paroxysmal positional vertigo on initial presentation and at the follow-up visit. Acta Otolaryngol 137:5485–5489

    Google Scholar 

  35. Jung HJ, Koo JW, Kim CS et al (2012) Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo. Acta Otolaryngol 132(3):277–284

    Article  PubMed  Google Scholar 

  36. Strupp M, Arbusow V, Brandt T (2001) Exercise and drug therapy alter recovery from labyrinth lesion in humans. Ann N Y Acad Sci 942(79):11

    Google Scholar 

  37. Modugno GC, Pirodda A, Ferri GG et al (2000) A relationship between autoimmune thyroiditis and benign paroxysmal positional vertigo? Med Hypotheses 54:614–615

    Article  CAS  PubMed  Google Scholar 

  38. Talaat HS, Kabel AM, Khaliel LH et al (2016) Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx 43(3):237–241

    Article  PubMed  Google Scholar 

  39. O'Connell MB, Madden DM, Murray AM et al (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118:778–781

    Article  CAS  PubMed  Google Scholar 

  40. Ivanovich P, Fellows H, Rich C (1967) The absorption of calcium carbonate. Ann Intern Med 66:917–923

    Article  CAS  PubMed  Google Scholar 

  41. Jansen JB, Klinkenberg-Knol EC, Meuwissen SG et al (1990) Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 99:621–628

    Article  CAS  PubMed  Google Scholar 

  42. Lindsay R, Nieves J, Formica C et al (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550–555

    Article  CAS  PubMed  Google Scholar 

  43. Ogun OA, Büki B, Cohn ES et al (2014) Menopause and benign paroxysmal positional vertigo. Menopause 21(8):886–889

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tiziana Di Cesare.

Ethics declarations

Conflict of interest

We have not received any funds from any kind of organization; the study is entirely the result of our work. We deny any kind of conflict of interest.

Research involving human participants and/or animals

This is not an experimental study, but a retrospective one, based on the analysis of data from medical records of patients referring to the Vestibular Service of our Institution.

Informed consent

Informed consent was obtained from patients at the time of their visit.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Picciotti, P.M., Di Cesare, T., Tricarico, L. et al. Is drug consumption correlated with benign paroxysmal positional vertigo (BPPV) recurrence?. Eur Arch Otorhinolaryngol 277, 1609–1616 (2020). https://doi.org/10.1007/s00405-020-05855-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-05855-6

Keywords

Navigation